证券记录 · 已归档季度
MD
Pediatrix Medical Group, Inc. · Healthcare · Medical - Care Facilities
14被追踪持有人
0Δ持有人
37.94M持有股份
$544.34M报告持仓市值
+2新建仓位
−2清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +1.8% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 14.44K | $378,853 | n/a | n/a |
| Q2 2026 | 97 | -3 | 57.25M | $1.45B | +5 | −8 |
| Q1 2026 | 103 | +4 | 59.12M | $1.26B | +9 | −5 |
| Q4 2025 | 99 | -1 | 67.55M | $1.45B | n/a | −1 |
| Q3 2025 | 18 | +1 | 40.93M | $685.43M | +1 | n/a |
| Q2 2025 | 14 | 0 | 37.94M | $544.34M | +2 | −2 |
| Q1 2025 | 11 | +1 | 9.91M | $143.46M | +1 | n/a |
| Q4 2024 | 10 | -3 | 9.74M | $127.83M | n/a | −3 |
| Q3 2024 | 12 | 0 | 6.92M | $79.97M | +1 | −1 |
| Q2 2024 | 12 | n/a | 7.89M | $59.29M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 13.95M | n/a | $200.16M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (被动) | 10.99M | n/a | $157.64M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 3.49M | -1.0% | $50.07M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 2.41M | n/a | $34.64M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 5 | Geode Capital Management ✦ (被动) | 2.00M | -0.8% | $28.69M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 1.58M | -15.7% | $22.64M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 1.20M | -1.4% | $17.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 643.29K | +129.4% | $9.23M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Point72 Asset Management ✦ | 550.84K | 新增 | $7.90M | 0.0% | New | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 394.93K | -13.9% | $5.59M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 11 | Millennium Management ✦ | 329.79K | +303.4% | $4.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 200.91K | 新增 | $2.88M | 0.0% | New | 1 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 115.37K | +54.8% | $1.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 85.58K | +6.2% | $1.23M | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $7.90M | 0.0% |
| Arrowstreet Capital | $2.88M | 0.0% |
已清仓
| Marshall Wace | $3.94M | 曾为 0.0% |
| Two Sigma Investments | $453,943 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 293 持有人, 82.31M 股份, $1.71B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Sep 03
SC 13G: VANGUARD CAPITAL MANAGEMENT LLC
Sep 03
SC 13G: VANGUARD PORTFOLIO MANAGEMENT LLC
Sep 03
SC 13G/A: VANGUARD GROUP INC
Jul 14
SC 13G: DIMENSIONAL FUND ADVISORS LP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据